Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Follicular Lymphoma (Phase 2)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04537715
What this trial is testing

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

Who this might be right for
All MalignanciesAdvanced MalignanciesHematologic Malignancy+9 more
Epizyme, Inc. 42
Testing effectiveness (Phase 2)Study completedNCT00073918
What this trial is testing

Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+14 more
Fred Hutchinson Cancer Center 111
Large-scale testing (Phase 3)Study completedNCT00003341
What this trial is testing

Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy

Who this might be right for
AnemiaLeukemiaLymphoma+1 more
Memorial Sloan Kettering Cancer Center 275
Early research (Phase 1)Ended earlyNCT01643603
What this trial is testing

Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's LymphomaMyeloid Leukemia+3 more
Barbara Ann Karmanos Cancer Institute 5
Testing effectiveness (Phase 2)WithdrawnNCT00746980
What this trial is testing

Efalizumab in the Treatment of Alopecia, Phase II

Who this might be right for
Alopecia Totalis
Northwestern University
Early research (Phase 1)Ended earlyNCT00671112
What this trial is testing

Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma

Who this might be right for
714leukemiaLymphoma
Brian Hill, MD, PhD 30
Testing effectiveness (Phase 2)UnknownNCT00008164
What this trial is testing

Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia

Who this might be right for
Childhood Langerhans Cell HistiocytosisLeukemiaLymphoma+3 more
Herbert Irving Comprehensive Cancer Center 30
Early research (Phase 1)Study completedNCT02950220
What this trial is testing

Pembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin LymphomaGrade 1 Follicular LymphomaGrade 2 Follicular Lymphoma+16 more
Kami Maddocks 2
Testing effectiveness (Phase 2)Study completedNCT00003039
What this trial is testing

Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma

Who this might be right for
Lymphoma
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Active Not RecruitingNCT04799275
What this trial is testing

Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma

Who this might be right for
Ann Arbor Stage III Diffuse Large B-Cell LymphomaAnn Arbor Stage IIX (Bulky) Diffuse Large B-Cell LymphomaAnn Arbor Stage IV Diffuse Large B-Cell Lymphoma+18 more
National Cancer Institute (NCI) 422
Testing effectiveness (Phase 2)Active Not RecruitingNCT06093841
What this trial is testing

Relmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHL

Who this might be right for
Lymphoma, Large B-Cell, DiffuseFollicular Lymphoma Grade 3BHigh-grade B-cell Lymphoma+1 more
Shanghai Ming Ju Biotechnology Co., Ltd. 46
Testing effectiveness (Phase 2)Study completedNCT00880581
What this trial is testing

Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas

Who this might be right for
Lymphoma, Non-HodgkinLymphomaLymphomas: Non-Hodgkin Follicular / Indolent B-Cell+1 more
Ronald Levy 30
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06961500
What this trial is testing

Obinutuzumab With CHOP Versus Obinutuzumab With Bendamustine in the Treatment of Newly Diagnosed Follicular Lymphoma Grade 3A

Who this might be right for
Follicular Lymphoma Grade 3A
Sun Yat-sen University 133
Not applicableStudy completedNCT00416312
What this trial is testing

Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Testing effectiveness (Phase 2)Study completedNCT01130194
What this trial is testing

Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
St. Louis University 29
Testing effectiveness (Phase 2)Study completedNCT03126019
What this trial is testing

INCB050465 in Relapsed or Refractory Follicular Lymphoma

Who this might be right for
Lymphoma
Incyte Corporation 126
Testing effectiveness (Phase 2)Study completedNCT00448201
What this trial is testing

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 71
Testing effectiveness (Phase 2)Looking for participantsNCT07191249
What this trial is testing

Trial to Evaluate Efficacy and Safety of Subcutaneous Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma .

Who this might be right for
Follicular Lymphoma
Tel-Aviv Sourasky Medical Center 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07505849
What this trial is testing

ZR2 Versus R2 Regimen in the Treatment of Newly Diagnosed Follicular Lymphoma

Who this might be right for
Follicular Lymphomas
KeshuZhou 100
Next Page